Press Releases


PepVax, Inc. Named “Best in Show” at 1st Pitch PA, October 16, 2017

PepVax, Inc. Wins “Best in Show” at Philadelphia 1st Pitch Life Science Competition October 17, 2017 09:35 ET | Source: Mid Atlantic Bio Angels NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that PepVax, Inc. (http://www.pepvax.co), which is developing a therapeutic treatment against triple negative breast cancer (TNBC), was named “Best in Show” by the investor panel at MABA’s 1st Pitch Life Science event held on October 5, 2017 […]


Mid Atlantic Bio Angels Invests in PainQx, Inc.

Mid Atlantic Bio Angels Invests in PainQx, Inc. Sept 08, 2017 | Source: Mid Atlantic Bio Angels NEW YORK, Sept. 08, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in New York and Philadelphia-based PainQx, Inc., which has developed an accurate and objective method to measure chronic and acute pain in humans. “Pain has long been subjective measurement, whether for hospitals, neurologists or other professionals working […]


Mid Atlantic Bio Angels Portfolio Company, Cerus Endovascular, Receives CE Mark for its Contour Neurovascular System for the Treatment of Intra-Cranial Aneurysms

Mid Atlantic Bio Angels Portfolio Company, Cerus Endovascular, Receives CE Mark for its Contour Neurovascular System for the Treatment of Intra-Cranial Aneurysms July 10, 2017 | Source: Mid Atlantic Bio Angels NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) — Cerus Endovascular Ltd., one of Mid Atlantic Bio Angels’ (MABA) portfolio companies, recently announced receipt of CE Mark approval for the commercial sale of its Contour Neurovascular System™ for the treatment of intra-cranial aneurysms (IAs) across […]


Recensa Therapeutics Wins “Best in Show” at 1st Pitch Life Science Competition NYC

Recensa Therapeutics was named“Best in Show” and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science NYC competition May 25, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis treatment designed to reduce oxidative stress, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at […]


BioCurrent Technologies Wins “Best in Show” at 1st Pitch Life Science Competition New Jersey

BioCurrent was named“Best in Show”at MABA’s 1st Pitch Life Science New Jersey competition April 18, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, May 01, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that BioCurrent Technologies (BioCurrent), a microbe-based, sustainable nanomaterials company, was named “Best in Show” by the audience and “Most Fundable” by the investor panel at MABA’s 1st Pitch Life Science New Jersey event held on April 18, 2017 at Rutgers University […]


Group K Diagnostics Wins “Best in Show” at 1st Pitch Life Science Competition Philadelphia March 20, 2017

Group K Diagnostics was named“Best in Show”at MABA’s 1st Pitch Life Science Philadelphia competition March 20, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, April 3, 2017 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a diagnostics company developing a multi-test modular point of care diagnostic platform, was named“Best in Show”at MABA’s 1st Pitch Life Science Philadelphia event held on March 20, 2017 at the Cira Center in Philadelphia. […]


One Three Biotech Named “Best-in-Show” at New York 1st Pitch Life Science Competition March 13, 2017

OneThree Biotech Wins “Best in Show” at 1st Pitch Life Science Competition Company’s Unique Process of Drug Targeting May Significantly Decrease Time to Development March 13, 2017 |  Source: Mid Atlantic Bio Angels NEW YORK, March 23, 2017 (GLOBE NEWSWIRE) — Mid Atlantic Bio Angels (MABA) announces today that OneThree Biotech (OneThree), a New York-based company developing artificial intelligence technology to more rapidly identify drug targets and side effects, was named “Best in Show” at […]


NangioTx, Wins Mid-Atlantic Bio Angels’ “Best of the Best” Year-End 1st Pitch Life Science Competition December 6, 2016

NangioTx Wins Mid-Atlantic Bio Angels’ “Best of the Best” Year-End 1st Pitch Life Science Competition Developer of Novel Drug that Promotes the Growth of New Blood Vessels in the Muscles of Patients with Peripheral Artery Disease  Named “Best of the Best” at New York-Based Event December 13, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK , Dec. 13, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that NangioTx, Inc.(http://www.nangiotx.com) was voted […]


VakSea Named “Best in Show” at 1st Pitch Baltimore, October 26, 2016

VakSea Wins Mid-Atlantic Bio Angels 1st Pitch Life Science Competition in Baltimore Developer of Oral Vaccines Against Nervous Necrosis Virus in Aquaculture Named “Best in Show” at Baltimore-Based Event November 11, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK, Nov. 11, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that VakSea, Inc. was named “Best in Show” at MABA’s inaugural 1st Pitch Life Science Baltimore event on October 26, 2016 at […]


Lynkogen and Dina Pharmaceuticals Best-in-Show at 1st Pitch New Jersey, November 1, 2016

Lynkogen, Inc. and Dina Pharmaceuticals, Inc. Selected as Co-Winners of 1st Pitch Life Science Competition, New Jersey Lynkogen, Developer of Protein Therapeutics for Rare and Prevalent Metabolic Diseaseses, and Dina Pharmaceuticals, Developers of a Novel Therapeutic for Parkinson’s Disease, was Named “Best in Show” at New Jersey-Based Event November 10, 2016 09:45 ET | Source: Mid Atlantic Bio Angels NEW YORK, Nov. 10, 2016 (GLOBE NEWSWIRE) — Mid-Atlantic Bio Angels (MABA) announces today that Lynkogen, […]